United Therapeutics Corporation annual revenue for fiscal 2025 was $3.2 billion, an increase of 10.6% from $2.9 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $3.2B | $2.9B | $2.3B | $1.9B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $782M | $790M | $800M | $799M | $794M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More UTHR metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow
All UTHR financial statements → Interactive UTHR charts →
About TickerBase · Data methodology & sources